in

Third phase trials in Turkey of the Chinese CoronaVac vaccine show an efficacy of 83.5%

Posted: Jul 12, 2021 02:32 GMT

Interim results of phase 3 trials carried out in Turkey with the Chinese CoronaVac vaccine against covid-19, showed an efficacy of 83.5% among the more than 10,000 volunteers between 18 and 59 years of age, reports the Daily Sabah newspaper, citing a study published in The Lancet.

The results show that the drug had a strong antibody response, while no serious side effects or deaths were reported among the volunteers. Side effects were minor, with the majority of adverse events of a mild nature and recorded within seven days after injection. The long-term efficacy of CoronaVac or against emerging variants such as Delta has not been studied.

Lying face down, Noelia shows her rear with a micro thong

Bill Gates and George Soros ‘come to the rescue’ to make up for London’s foreign aid cuts (but their goals raise doubts)